{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:47:42Z","timestamp":1792176462378,"version":"4.4.0"},"reference-count":9,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1590\/abd1806-4841.20175070","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T13:12:32Z","timestamp":1487596352000},"page":"139-141","source":"Crossref","is-referenced-by-count":50,"title":["Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials"],"prefix":"10.1590","volume":"92","author":[{"given":"Romi","family":"Bloom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Northshore University Health System,  USA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Amber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"University of California Irvine,  USA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","first-page":"CD001031","article-title":"Lamotrigine versus carbamazepine monotherapy for epilepsy","volume":"1","author":"Gamble CL","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.4088\/JCP.12r08046","article-title":"Lamotrigine in psychiatric disorders","volume":"74","author":"Reid JG","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/pds.1690","article-title":"Trends and changes in the clinical use of lamotrigine","volume":"18","author":"Reimers A","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.seizure.2014.12.001","article-title":"Risk of a lamotriginerelated skin rash: current meta-analysis and postmarketing cohort analysis","volume":"25","author":"Wang XQ","year":"2015","journal-title":"Seizure"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt M","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/ijd.12570","article-title":"Association of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis","volume":"54","author":"Zeng T","year":"2015","journal-title":"Int J Dermatol"},{"key":"ref7","first-page":"107","article-title":"HLA-B*1502 increases the risk of phenytoin or lamotrigine induced Stevens-Johnson Syndrome\/toxic epidermal necrolysis: evidence from a meta-analysis of nine case-control studies","volume":"65","author":"Li X","year":"2015","journal-title":"Drug Res (Stuttg)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00228-014-1764-0","article-title":"Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine","volume":"71","author":"Park HJ","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients","volume":"126","author":"Chan HL","year":"1990","journal-title":"Arch Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v92n1\/0365-0596-abd-92-01-0139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:44Z","timestamp":1747666844000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962017000100139&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0365-05962017000100139"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20175070","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}